Microdosing mushrooms, particularly psilocybin-containing varieties, has captured the curiosity of individuals seeking subtle cognitive enhancements and alternative approaches to mental health. We will look at the science behind the microdosing practice, as well as the mechanisms that may be involved and scientific findings which are beginning shed light on it.
In microdosing, psychedelics like psilocybin are taken in sub-perceptual amounts at intervals. Microdosing has a secondary goal, which is to maximize the cognitive and psychological benefits of psychedelics.
In recent years, researchers have begun to understand the mechanism behind microdosing. Psilocybin in small doses interacts to the brain’s serotonin-receptors. This can result in subtle changes to mood, creativity, cognition and other aspects of the brain.
A micro-dosing mechanism may be one way of increasing neuroplasticity – the brain’s capability to organize itself and form new connections. This improved neuroplasticity can lead to improvements in learning, creativity and mood regulation. Several studies suggest that psilocybin promotes the growth of neurons which can further enhance cognitive enhancement.
A microdosing could also affect the default mode (DMN) network. This is a part of the brain that’s associated with thoughts about self and mind wandering. Dysregulation of DMN was linked to anxiety and depression. Psilocybin could be used in small amounts to reset the DMN. This may help alleviate symptoms.
Although the science of microdosing mushroom is in its beginning stages, there are a number of studies and reports that suggest the practice has promise. Microdosing mushrooms is not for everyone. It’s important to be cautious, measure your doses carefully, and seek medical advice if you are interested.
As a conclusion, the field of microdosing is one that has been steadily uncovering its possible mechanisms and benefits. The science behind microdosing is becoming more clear as research progresses.